Chongqing Pharscin Pharmaceutical (SHE:002907) paid 7.2 million yuan in enterprise income tax and 2.8 million yuan in late fees.
The 10.0-million-yuan payment stemmed from discrepancies in the tax and accounting treatment of convertible bond interest expenses, according to a Tuesday filing with the Shenzhen bourse.
Shares of the pharmaceutical company closed 6% lower Thursday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments